At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 57 enrolled
Drug / intervention
Test Eye Drops +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of Two Marketed Artificial Tears in Non-contact Lens Wearing Patients
In Brief
A Phase 4 clinical trial evaluating Test Eye Drops and Control Eye Drops for Visual Acuity. Completed, enrolled 57 participants across 1 site.
Detailed Summary
This clinical study is a randomized, double-masked, cross-over, bilateral, 2 treatment x 2 period, dispensing 4-visit study with a 7-9 day washout period in between visits 2 and 3. The study will last approximately 3 months.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited Kingdom
Collaborators--
Timeline
Phase 4CompletedFinished
201820192020202120222023202420252026
Enrollment StartFeb 2018
First PostedMar 2018
Primary CompletionMay 2018
TodayJul 2026
First PostedMar 15, 2018
Enrollment StartFeb 9, 2018
Primary CompletionMay 16, 2018
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 8.3 years ago
Interventions
Test Eye Dropsdevice
blink® intensive TRIPLE ACTION 3 in 1 eye drops
Control Eye Dropsdevice
Systane® BALANCE eye drops